Buy Carbidopa + Levodopa
Carbidopa + Levodopa

0.59
Generic Carbidopa + Levodopa is a dopaminergic combination used to treat symptoms of Parkinson's disease. Levodopa is converted into dopamine in the brain, while Carbidopa prevents its premature breakdown. This combination helps patients improve muscle control, reducing tremors, stiffness, and slow movement associated with neurological conditions.


Ingredients
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Levodopa, Carbidopa
Reference Brand
Sinemet
Product Form
Tablet, Modified-release tablet
Regulatory Classification
Rx
Primary Category
Parkinson's Disease
Product Category
Central Nervous System, Dopaminergic drugs
Pharmacological Class
Dopa-decarboxylase inhibitors, Dopamine precursors
Manufacturer Description
The primary treatment for managing the movement symptoms of Parkinson's disease.
Mechanism of Action
Levodopa is converted into dopamine in the brain to help manage movement. Carbidopa is added to prevent Levodopa from breaking down before it reaches the brain, reducing side effects like nausea.
Route of Administration
Oral
Onset Time
30-60 minutes
Duration
3-5 hours
Contraindications
Narrow-angle glaucoma, Suspicious undiagnosed skin lesions, History of melanoma
Severe Adverse Events
Depression, Suicidal thoughts, Hallucinations, Irregular heartbeat
Common Side Effects
Nausea, Dizziness, Loss of appetite
Uncommon Side Effects
Involuntary movements, Dry mouth, Sleepiness, Vivid dreams
Drug Interactions
MAO inhibitors, Iron supplements, High protein meals, Antipsychotics
Pregnancy Safety Warnings
Only use if benefits outweigh risks to the fetus.
Age Restrictions
Adult use only; safety in children unknown.
Storage Guidelines
Keep container tightly closed and protect from light.
Related Products

Carbidopa + Levodopa FAQ

Can I take Carbidopa + Levodopa with a high-protein diet?

Levodopa competes with dietary amino acids for transport across the intestinal lining and the blood-brain barrier. A high-protein meal taken close to dosing may reduce drug absorption and lessen its effectiveness. Many clinicians advise spacing protein-rich meals at least 1-2 hours before or after taking the medication.

What should I do if I experience sudden severe nausea after a dose?

Mild nausea is common, but severe or persistent nausea may indicate that the dose is too high or that the tablet was taken on an empty stomach. Contact your healthcare provider; they may adjust the dose, suggest taking the tablet with a small snack, or add an anti-emetic medication.

Is it safe to travel internationally with Carbidopa + Levodopa?

Yes, but carry the medication in its original labelled container, bring a copy of the prescription, and keep it in your hand luggage to avoid temperature extremes. Check the destination country’s regulations for importing prescription medicines; the UK MHRA provides guidance for travelers.

Can I use over-the-counter supplements like Vitamin B6 with this medicine?

High doses of Vitamin B6 (pyridoxine) can increase peripheral metabolism of levodopa, potentially reducing its effectiveness. Low-dose supplementation (≤ 10 mg) is generally considered safe, but discuss any supplement use with your prescriber.

How does alcohol affect my Parkinson’s medication?

Alcohol can exacerbate levodopa-induced dizziness and orthostatic hypotension, increasing fall risk. Moderate consumption may be tolerated, but heavy drinking should be avoided, especially during dose titration.

What are the signs of a hypertensive crisis if I accidentally combine this drug with a non-selective MAO inhibitor?

Symptoms include sudden, severe headache, chest pain, rapid heartbeat, shortness of breath, and visual disturbances. This is a medical emergency; seek immediate care. Always ensure a minimum 14-day washout period after stopping a non-selective MAO inhibitor before starting Carbidopa + Levodopa.

Do I need to adjust my dose if I develop kidney problems?

Levodopa and carbidopa are partially excreted by the kidneys. In moderate to severe renal impairment, the drug may accumulate, increasing the risk of side effects. Dose reduction and close monitoring are recommended; your clinician will determine the appropriate adjustment.

What should I know about using this medication if I work as a pilot or driver?

Regulatory agencies often require documentation of stable motor control before granting or renewing a licence. Because levodopa can cause sudden “off” periods or dyskinesia, you should discuss your occupation with a neurologist to ensure your condition is well-controlled and safe for duty.

Are there generic versions of Carbidopa + Levodopa available in the UK?

Yes, the combination is available as a generic prescription product containing the same strengths (e.g., 25 / 100 mg). Generic tablets must meet the same quality standards as brand-name equivalents and are approved by the MHRA.

What is Carbidopa + Levodopa?

Carbidopa + Levodopa is a prescription pill that combines two active ingredients-levodopa and carbidopa-to treat the motor symptoms of Parkinson’s disease. Levodopa is converted in the brain to dopamine, the neurotransmitter that is deficient in Parkinson’s disease, while carbidopa inhibits the peripheral breakdown of levodopa, allowing more of the drug to reach the brain. In the United Kingdom the combination is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is only available with a prescription.

Available strengths (carbidopa / levodopa): 10 / 100 mg, 25 / 100 mg, 25 / 250 mg, 50 / 200 mg.

The medication is supplied as a standard oral tablet and is intended for adult patients with a clinical diagnosis of Parkinson’s disease.

How Carbidopa + Levodopa Works in the Body

  • Levodopa is a precursor of dopamine. After oral ingestion, it is absorbed into the bloodstream and crosses the blood-brain barrier where it is decarboxylated to dopamine, replenishing the deficient neurotransmitter that controls movement.
  • Carbidopa does not cross the blood-brain barrier. It blocks the enzyme aromatic L-amino-acid decarboxylase (AADC) in peripheral tissues, preventing levodopa from being converted to dopamine outside the brain. This results in:
  • Higher bioavailability of levodopa (more reaches the central nervous system).
  • Reduced peripheral side effects such as nausea, vomiting, and cardiovascular disturbances.
  • The combination produces a relatively rapid onset of symptom relief (typically within 30-60 minutes) and a duration of action that depends on the dose and individual metabolism, usually lasting 3-4 hours per dose.

Conditions Treated by Carbidopa + Levodopa

In the UK, the MHRA has approved Carbidopa + Levodopa for the following indication:

  • Parkinson’s disease - to improve motor symptoms such as bradykinesia, rigidity, tremor, and postural instability in adults.

The medication is prescribed when patients either have not responded adequately to dopamine agonists or when the disease stage requires more robust dopaminergic stimulation.

Off-Label and Investigational Applications

Evidence from clinical studies has explored additional uses for levodopa-based therapy, but none are approved by the MHRA for these purposes. Examples include:

  • Restless Legs Syndrome (RLS) - small trials suggest benefit, but the evidence is limited and the use remains off-label. Disclaimer: Off-label use requires medical supervision and individualized risk assessment.

  • Apathy in neurodegenerative disorders - some experimental protocols evaluate levodopa’s effect on motivation, but data are preliminary.

No other off-label indications have strong, guideline-supported evidence, so they are omitted from routine practice.

Who Should (Not) Use Carbidopa + Levodopa?

Absolute Contraindications

  • Known hypersensitivity to levodopa, carbidopa, or any excipients in the tablet.
  • Use of non-selective monoamine-oxidase inhibitors (MAO-I) such as phenelzine or tranylcypromine (must be discontinued at least 14 days before starting).
  • Narrow-angle glaucoma or a history of malignant melanoma (levodopa can exacerbate intra-ocular pressure and pigment-related conditions).

Relative Contraindications / Cautions

  • Pregnancy and lactation - limited human data; use only if the potential benefit outweighs the risk.
  • Severe renal or hepatic impairment - may require dose adjustments; monitor closely.
  • Cardiovascular disease - levodopa can cause orthostatic hypotension; start with lower doses.
  • Psychiatric disorders - patients with a history of psychosis may develop hallucinations or worsening symptoms.

Special Populations

  • Elderly patients often require lower starting doses and slower titration due to increased sensitivity to side effects.
  • Patients with dysphagia - tablets should be swallowed whole; crushing may affect drug release.

Safety Profile and Interactions

Common Side Effects

  • Nausea and vomiting
  • Orthostatic hypotension (dizziness upon standing)
  • Loss of appetite
  • Dry mouth
  • Sleep disturbances (insomnia or vivid dreams)

These effects are usually mild and improve with dose adjustment.

Serious Adverse Events

  • Dyskinesia (involuntary, erratic movements) - often dose-related.
  • Hallucinations or psychosis - more common in older patients or those with pre-existing psychiatric conditions.
  • Severe hypotension leading to fainting.
  • Neuroleptic malignant-like syndrome (rare, associated with abrupt withdrawal).

If any of these occur, seek immediate medical attention.

Major Drug Interactions

  • Non-selective MAO inhibitors - can precipitate hypertensive crisis; must be stopped ≥ 14 days before initiating Carbidopa + Levodopa.
  • Selective MAO-B inhibitors (e.g., selegiline, rasagiline) - generally safe when used at approved Parkinson’s doses, but concurrent use should be monitored.
  • Antipsychotics (e.g., haloperidol, clozapine) - antagonize dopamine receptors, reducing therapeutic effect.
  • Anticholinergics (e.g., benztropine) - may increase levodopa’s central effects and risk of confusion.

Moderate Interactions

  • Iron, vitamin C, or dietary supplements - may reduce levodopa absorption if taken simultaneously.
  • High-protein meals - compete for transport across the gut and blood-brain barrier, potentially decreasing levodopa’s efficacy.

Food and Lifestyle Interactions

  • Protein-restricted diet: Some clinicians advise spacing protein intake away from levodopa dosing (e.g., taking medication 30 minutes before or 2 hours after a high-protein meal) to improve absorption.
  • Alcohol - can enhance dizziness and orthostatic hypotension; moderate consumption is advisable.
  • Driving or operating machinery - patients should assess personal response, especially during dose titration, as levodopa may cause sudden changes in motor function.

Safety tip: Always inform your healthcare provider of all medications, supplements, and herbal products you are taking before starting Carbidopa + Levodopa.

How to Take Carbidopa + Levodopa

  • Standard dosing (based on available strengths):

  • Initial therapy often starts with 25 / 100 mg taken three times daily (before meals).

  • Doses are titrated upward in increments of 25 / 100 mg or 50 / 200 mg based on symptom control and side-effect profile.

  • The maximum recommended daily levodopa dose is typically 800 mg (equivalent to four 25 / 200 mg tablets), but individual needs may vary.

  • Administration tips:

  • Swallow tablets whole with a small amount of water.

  • Take the medication 30 minutes before meals or 1 hour after a protein-rich meal to maximize absorption.

  • Do not crush or chew tablets unless a specific formulation (e.g., dispersible) is prescribed.

  • Missed dose:

  • Take the missed dose as soon as you remember if it is more than 4 hours before the next scheduled dose.

  • Do not double the dose to make up for a missed one.

  • Overdose:

  • Symptoms may include severe nausea, vomiting, confusion, agitation, and cardiac arrhythmias.

  • Seek emergency medical care immediately; treatment is supportive and may involve gastric lavage and symptomatic management.

  • Discontinuation:

  • Abrupt stopping can cause a sudden worsening of Parkinsonian symptoms and a “withdrawal” dyskinesia.

  • Tapering under medical supervision is recommended, especially after long-term use.

Monitoring and Follow-Up

  • Clinical assessment every 3-6 months to evaluate motor improvement, dyskinesia development, and mental status.
  • Blood pressure measurements if orthostatic symptoms are reported.
  • Renal and hepatic function tests annually, or more frequently if underlying disease exists.
  • Medication review at each visit to identify potential drug interactions or the need for dose adjustments.

Regular follow-up ensures optimal symptom control while minimizing adverse effects.

Storage and Handling

  • Store tablets at room temperature (≤ 25 °C), away from excess moisture and direct sunlight.
  • Keep the container tightly closed and out of reach of children.
  • Do not use the medication after the expiration date printed on the package.
  • If a tablet becomes discolored, crumbly, or smells unusual, discard it according to local pharmacy waste guidelines.

Medication-Specific Glossary

Levodopa
A precursor of dopamine that crosses the blood-brain barrier and is enzymatically converted to dopamine within the central nervous system.
Carbidopa
An inhibitor of peripheral aromatic L-amino-acid decarboxylase, which prevents premature conversion of levodopa to dopamine outside the brain.
Dyskinesia
Involuntary, erratic movements that can emerge after chronic levodopa therapy, often linked to high dopaminergic stimulation.
Bioavailability
The proportion of an administered dose that reaches systemic circulation; for levodopa, bioavailability is markedly increased when combined with carbidopa.
Motor fluctuations
Variations in the effectiveness of Parkinson’s medication, manifesting as “on” periods (good symptom control) and “off” periods (return of symptoms).

Medical Disclaimer

This article provides educational information about Carbidopa + Levodopa and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Carbidopa + Levodopa is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories
Waar kunt u Gezondheid van Vrouwen kopen - Dydrogesteron bestellen Prescription options for Pain Relief Medication Hong Kong: - Buy Methocarbamol Hong Kong